Enzymatic formation of psychotomimetic metabolites from normally occurring compounds - PubMed (original) (raw)
Enzymatic formation of psychotomimetic metabolites from normally occurring compounds
J AXELROD. Science. 1961.
Abstract
An enzyme has been found that N-methylates serotonin and tryptamine to psychotomimetic metabolites, bufotenine and N,N-dimethyltryptamine. This enzyme is highly localized in the rabbit lung and also N-methylates phenylethylamine derivatives such as tyramine, phenylethylamine , mescaline, and dopamine.
Similar articles
- Further studies on the mode of action of psychotomimetic drugs: antagonism of the excitatory actions of 5-hydroxytryptamine by methylated derivatives of tryptamine.
Bradley PB, Briggs I. Bradley PB, et al. Br J Pharmacol. 1974 Mar;50(3):345-54. doi: 10.1111/j.1476-5381.1974.tb09609.x. Br J Pharmacol. 1974. PMID: 4277490 Free PMC article. - A possible mechanism for the antischizophrenic action of chlorpromazine: inhibition of the formation of dimethyltryptamine by chlorpromazine metabolites.
Narasimhachari N, Lin RL. Narasimhachari N, et al. Res Commun Chem Pathol Pharmacol. 1974 Jun;8(2):341-51. Res Commun Chem Pathol Pharmacol. 1974. PMID: 4527612 No abstract available. - A review of recent studies of the biosynthesis and excretion of hallucinogens formed by methylation of neurotransmitters or related substances.
Rosengarten H, Friedhoff AJ. Rosengarten H, et al. Schizophr Bull. 1976;2(1):90-105. doi: 10.1093/schbul/2.1.90. Schizophr Bull. 1976. PMID: 779022 Review. No abstract available. - N, N-dimethyltryptamine: an endogenous hallucinogen.
Barker SA, Monti JA, Christian ST. Barker SA, et al. Int Rev Neurobiol. 1981;22:83-110. doi: 10.1016/s0074-7742(08)60291-3. Int Rev Neurobiol. 1981. PMID: 6792104 Review. No abstract available. - N,N-dimethyltryptamine--a possible relationship to schizophrenia?
Wyatt RJ, Gillin JC, Kaplan J, Stillman R, Mandel L, Ahn HS, VandenHeuvel WJ, Walker RW. Wyatt RJ, et al. Adv Biochem Psychopharmacol. 1974;11(0):299-313. Adv Biochem Psychopharmacol. 1974. PMID: 4602668 Review. No abstract available.
Cited by
- [Quantitative determination of an increased excretion of bufotenin in urine of schizophrenics].
Fischer E, Spatz H. Fischer E, et al. Arch Psychiatr Nervenkr (1970). 1968;211(3):241-9. doi: 10.1007/BF00340822. Arch Psychiatr Nervenkr (1970). 1968. PMID: 5704324 German. No abstract available. - Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
Cozzi NV, Gopalakrishnan A, Anderson LL, Feih JT, Shulgin AT, Daley PF, Ruoho AE. Cozzi NV, et al. J Neural Transm (Vienna). 2009 Dec;116(12):1591-9. doi: 10.1007/s00702-009-0308-8. Epub 2009 Sep 12. J Neural Transm (Vienna). 2009. PMID: 19756361 - Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain.
Dean JG, Liu T, Huff S, Sheler B, Barker SA, Strassman RJ, Wang MM, Borjigin J. Dean JG, et al. Sci Rep. 2019 Jun 27;9(1):9333. doi: 10.1038/s41598-019-45812-w. Sci Rep. 2019. PMID: 31249368 Free PMC article. - Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.
Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C. Cumming P, et al. Molecules. 2021 Apr 22;26(9):2451. doi: 10.3390/molecules26092451. Molecules. 2021. PMID: 33922330 Free PMC article. Review. - Stimulus properties of mescaline and N-methylated derivatives: difference in peripheral and direct central administration.
Browne RG, Harris RT, Ho BT. Browne RG, et al. Psychopharmacologia. 1974;39(1):43-56. doi: 10.1007/BF00421457. Psychopharmacologia. 1974. PMID: 4425137 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources